Diagnostic considerations and treatment differ in a few key ways for pediatric cases ...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained ...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD and co-morbidities.

Drs. Jessa Miller and Amrita Ray discuss the paradox of increasing incidence and decreasing mortality in AIFRS.

Climate change might intensify dust storms, causing more respiratory health risks.

Every spring, millions of Americans start tracking sneezing, congestion, and itchy eyes. In 2026, that yearly check-in sounds ...

Long-term use of systemic corticosteroids is linked to adrenal insufficiency and related hospitalisation, whereas long-term use of inhaled corticosteroids is modestly linked to adrenal insufficiency.

PHOENIX — For several minutes on Monday, Miguel Rojas said his world “rumbled.” For several minutes that afternoon, the ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

The Food and Drug Administration issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side effects in patients who took its blockbuster ...

Dr. Kevin Kalinsky discusses common side effects associated with the FDA-approved combination of Enhertu and Perjeta for ...